Tilray Cannabis Stock Momentum Weakens Amid Federal Rescheduling Uncertainty

Shares of Tilray continue to lose ground as investor enthusiasm fades over the delayed federal rescheduling of marijuana, raising questions about the company's near-term trajectory if political progress stalls.